|
Recent Developments |
|
17-NOV-16
Sanofi India (SIL), the leading pharmaceutical companies of the world, has signed a Memorandum of Understanding (MoU) with NIPER Kolkata, an autonomous body set up under the aegis of Department of Pharmaceuticals
30-NOV-15
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first shipment of ShanIPV, a brand new injectable, inactivated polio vaccine (IPV) manufactured by its affiliate Shantha Biotechnics
27-MAY... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 30-Jun-2021(6) | 31-Dec-2020 (12) | 31-Dec-2019 (12) | | Net sales | 15142.00 | 29019.00 | 30706.00 | | Other Income | 434.00 | 898.00 | 941.00 | | Total Income | 15576.00 | 29917.00 | 31647.00 | | Cost of goods sold | -11201.00 | -22728.00 | -25055.00 | | OPBDIT | 26777.00 | 52645.00 | 56702.00 | | PAT | 3242.00 | 4776.00 | 4142.00 | | Gross Block | - | - | - | | Equity capital | - | 0.00 | 0.00 | | EPS (Rs.) | - | 0.00 | 0.00 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 171.9 | 176.0 | 179.2 | | Net margin (% of OI) | 20.8 | 16.0 | 13.1 |
|
|
Detailed Financials
|
|
|
|
|
